Our Newly Acquired Assets

Boehringer Ingelheim Vetmedica is committed to the long-term growth of its animal health business. The acquisition of many Fort Dodge Animal Health products represents a unique opportunity for BIVI to increase our portfolio in the pet, equine and cattle markets. In addition, the acquisition allows BIVI to increase its already substantial investment in the development of innovative biological and pharmaceutical animal health products. Please download the detailer and learn more about this exciting opportunity for our partners and customers.

For those seeking more details about Boehringer Ingelheim's acquisition of of many Fort Dodge Animal Health products, a detailer (PDF 3.7MB) has been created to answer questions and introduce the expanded Boehringer Ingelheim Vetmedica, Inc. (BIVI) product portfolio. We hope to share with you our excitement and the opportunities it gives us to work and grow together.